Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. | MicrobiomeTrials← Back to trialsNCT07165132
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-12-03Est. Completion: 2027-02
Enrollment target: 104 participants Locations- Research Facility, Iowa City, Iowa, United States
- Research Facility, Lexington, Kentucky, United States
- Research Facility, St Louis, Missouri, United States
- Research Facility, St Louis, Missouri, United States
- Research Facility, Columbus, Ohio, United States
- Research Facility, Nashville, Tennessee, United States
- Research Facility, Salt Lake City, Utah, United States
- Research Facility, Toronto, Ontario, Canada
- Research Facility, Montreal, Quebec, Canada
Other microbiome trials you might be interested in
Gastroenteropancreatic Neuroendocrine Tumor
This study aims to characterize current treatment patterns and clinical outcomes among newly diagnosed GEP-NET patients …
Multiple LocationsEst. completion Feb 25, 2027
Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid TumorRefractory Solid TumorsSolid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028